Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

TCT 2024 | Distal Radial vs Transradial Approach in STEMI Patients

The transradial approach (TRA) has been recommended for patients with ST-elevation myocardial infarction (STEMI) for reduced bleeding complications and mortality. However, evidence in support of the use of distal radial access (DRA) in these patients is limited. This study aimed at showing DRA puncture success rate would be no inferior than that of TRA.

Primary endpoint was puncture success rate. Secondary endpoints included coronary angiography and angioplasty success rates, bleeding complications, puncture, procedural, hemostasis and fluoroscopy time, contrast volume, and major adverse cardiovascular events (MACE), including all-cause death, myocardial infarction, and revascularization.

A total of 354 patients were randomized: 174 were assigned to DRA and 175 to TRA. Puncture success rate resulted 94.3% for DRA patients vs. 96.1% for TRA. 

Read also: STEACS and the Use of Bivalirudin vs. Heparin: In Search of BRIGHT-4 Outcomes.

Access site bleeding was more frequent among TRA patients vs. DRA, though not statistically significant. No significant differences were found when looking at secondary endpoints.

Conclusión  

In this multicenter study of STEMI patients, DRA vs TRA puncture success rate resulted inconclusive in both intention-to-treat and per-protocol analyses. However, DRA was shown non-inferior based on treatment. Large-scale studies are needed to confirm these findings.

Original Title: Comparison of Puncture Success Rate between Distal Radial Access and Transradial Access in Patients with ST-elevation Myocardial Infarction.

Reference: Jun-Won LEE, MD, PhD et al TCT 2024.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Andrés Rodríguez
Dr. Andrés Rodríguez
Member of the Editorial Board of solaci.org

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...